Nunzia Pharmaceutical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 14, 2022 at 08:01 am EST
Nunzia Pharmaceutical Company reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 0.236416 million compared to USD 0.034526 million a year ago.
For the nine months, net loss was USD 18.98 million compared to USD 0.056803 million a year ago. Basic loss per share from continuing operations was USD 0.04.